Hepatitis C Virus Genetic Diversity and Drug Mutational Analysis in Cameroon: 1992 to 2013
Judith Ndongo Torimiro, Laure Arlette Tchapda, Maurice Boda, Jude Saber Bimela, Dale Netski, Desire Takou, Donald Scot Burke, Ubald Tamoufe, Eitel Mpoudi-Ngole, Henry Namme Luma, Oudou Njoya, Wilfred Fon Mbacham, Nathan Wolfe & Stuart Ray · Microbiology Research Journal International · 2016
HCV infection is endemic in Cameroon. A Direct acting agent (DAAs), sofosbuvir that target the HCV non-structural 5B RNA-dependent RNA polymerase (NS5B RdRp) has recently been incorporated into the standard of care in Cameroon but no drug resistance study to this DAA has been rep...